
On closing a $38M Series A without a bridge round and executing on time - Hélène Briand, Verley Food
Investment Climate · Alex Shandrovsky
Audio is streamed directly from the publisher (api.riverside.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Episode 80: Verley Food: Hélène Briand on closing a $38M Series A without a bridge round and executing on time
In this episode, I sit down with Hélène Briand, Co-founder and Chief Innovation & Commercial Officer at Verley Food, a French precision fermentation company that recently made headlines by closing a massive $38M Series A led by Alvin. Hélène reveals the disciplined, milestone-obsessed playbook that allowed them to go from Seed to Series A without needing a bridge round. We discuss how she proved commercial traction before having a product to sell by putting prospective customers directly on the phone with investors, why they chose to scale up with a North American CDMO rather than building their own CapEx-heavy facility, and how they secured a crucial "No Questions" letter from the FDA in record time.
🎧 Listen to the full episode to hear why Hélène hired dedicated Project Managers to keep scientists on schedule and why focus is the ultimate fundraising hack.
Key Facts Verley Food:
- Goal: To develop the next generation of functionalized whey protein (BLG) for the food industry using precision fermentation.
- Milestone: Raised a $38M Series A (including significant non-dilutive backing from Bpifrance) and secured a "No Questions" letter from the FDA.
Alex’s Top Findings:
- The Power of Hitting Milestones (No Bridge Required). The FoodTech industry is notorious for delayed timelines and endless bridge rounds. Verley Food stands out because they actually delivered on the exact scientific and regulatory milestones they promised their Seed investors. Hélène attributes this to intense focus (refusing to expand beyond BLG protein) and the crucial decision to hire dedicated, non-lab-working Project Managers whose sole job is to keep the scientific team executing on schedule. "We eat on time and we have been overachieving it. And this has made the difference... We hired two project managers dedicated to execution and project management... They're not working in the lab. They're just here to manage the milestone and building the mitigation plan."
- Proving Market Traction Pre-Commercialization. How do you prove traction when you don't have volume to sell? Verley Food didn't rely on theoretical TAM charts. They built an in-house applications team to solve specific pain points for FMCGs (like creating highly stable, high-protein acidic beverage shots). When it came time to fundraise, Hélène put those prospective customers directly on the phone with the VCs to vouch for the immediate market need. "We also are lucky to have good relationships with [our customers] to be able to discuss directly with our investors. So it was first of all allowing investors to touch the credibility as well on the market so they had direct access... They get on call with investors directly and we are not involved."
- The Strategic CDMO Choice (And Why North America). Rather than burning capital building their own facility in France, Verley opted to scale through a Contract Development and Manufacturing Organization (CDMO) in North America. Hélène explains that finding a partner with the exact downstream filtration equipment and the "agility" to handle a startup's pace was more important than simply chasing the cheapest labor costs in Asia, especially since they are targeting a premium, high-margin functional ingredient market. "I realized how hard is it when you are in your company to handle your R&D... and on top of it manage with industrial equipment... We are leveraging CMO as much as we can until we fully de-risk the technology at industrial scale... You can make two times trying CMO all around the world. Yes, it's about price, but it is not our first criteria."